Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory properties

Hiremagalur N. Jayaram, Gurpreet S. Ahluwalia, Robert L. Dion, Gulilat Gebeyehu, Victor E. Marquez, James A. Kelley, Roland K. Robins, David A. Cooney, David G. Johns

Research output: Contribution to journalArticle

59 Scopus citations
Original languageEnglish (US)
Pages (from-to)2633-2636
Number of pages4
JournalBiochemical Pharmacology
Volume32
Issue number17
DOIs
StatePublished - Sep 1 1983

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Jayaram, H. N., Ahluwalia, G. S., Dion, R. L., Gebeyehu, G., Marquez, V. E., Kelley, J. A., Robins, R. K., Cooney, D. A., & Johns, D. G. (1983). Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory properties. Biochemical Pharmacology, 32(17), 2633-2636. https://doi.org/10.1016/0006-2952(83)90038-2